Invited commentary: Is indoor mold exposure a risk factor for asthma?

American Journal of Epidemiology

Volumn 158, Issue 3, 2003, Pages 203-206

  Douwes, Jeroen ^a,b   Pearce, Neil ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ENDOTOXIN; IMMUNOGLOBULIN E;

ASTHMA; RISK FACTOR;

AIR POLLUTANT; ALLERGIC REACTION; ASTHMA; ATOPY; COUGHING; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FUNGUS CULTURE; FUNGUS SPORE; HUMAN; HYGIENE; MOTHER; MOULD; NONHUMAN; NOTE; QUESTIONNAIRE; RISK FACTOR; SYMPTOMATOLOGY; WHEEZING;

ADULT; AIR POLLUTION, INDOOR; ALLERGENS; ASTHMA; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGI; HUMANS; INFANT; INFANT, NEWBORN; MALE; ODDS RATIO; RISK FACTORS; WATER;

EID: 0041626196     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg149     Document Type: Note

References (46)

1. Brunekreef B, Dockery D, Speizer F, et al. Home dampness and respiratory morbidity in children. Am Rev Respir Dis 1989;140:1363-7.
2. Andriessen JW, Brunekreef B, Roemer W. Home dampness and respiratory health status in European children. Clin Exp Allergy 1998;28:1191-200.
3. Peat JK, Dickerson J, Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy 1998;53:120-8.
4. Nafstad P, Oie L, Mehl R, et al. Residential dampness problems and symptoms and signs of bronchial obstruction in young Norwegian children. Am J Respir Crit Care Med 1998;157:410-14.
5. Øie L, Nafstad P, Botten G, et al. Ventilation in homes and bronchial obstruction in young children. Epidemiology 1999;10:294-9.
6. Norback D, Bjornsson E, Janson C, et al. Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings. Int J Tuberc Lung Dis 1999;3:368-76.
7. Kilpeläinen M, Terho EO, Helenius H, et al. Home dampness, current allergic diseases, and respiratory infections among young adults. Thorax 2001;56:462-7.
8. Bornehag CG, Blomquist G, Gyntelberg F, et al. Dampness in buildings and health: Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). Indoor Air 2001;11:72-86.
9. Zock JP, Jarvis D, Luczynska C, et al. Housing characteristics, reported mold exposure, and asthma in the European Community Respiratory Health Survey. J Allergy Clin Immunol 2002;110:285-92.
10. Zheng T, Niu S, Lu B, et al. Childhood asthma in Beijing, China: a population-based case-control study. Am J Epidemiol 2002;156:977-83.
11. Engvall K, Norrby C, Norback D. Asthma symptoms in relation to building dampness and odour in older multifamily houses in Stockholm. Int J Tuberc Lung Dis 2001;5:468-77.
12. Jaakkola MS, Nordman H, Piipari R, et al. Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study. Environ Health Perspect 2002;110:543-7.
13. Verhoeff AP, Burge HA. Health risk assessment of fungi in home environments. Ann Allergy Asthma Immunol 1997;78:544-56.
14. Garrett MH, Rayment PR, Hooper MJ. Indoor fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 1998;28:459-67.
15. Jacob B, Ritz B, Gehring U, et al. Indoor exposure to molds and allergic sensitisation. Environ Health Perspect 2002;110:647-53.
16. Belanger K, Beckett W, Triche E, et al. Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma. Am J Epidemiol 2003;158:195-202.
17. Gent JF, Ren P, Belanger K, et al. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect 2002;110: A781-6.
18. Martinez FD, Wright AL, Taussig LM. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
19. Hunter CA, Grant C, Flannigan B, et al. Mould in buildings: the air spora of domestic dwellings. Int Biodeterior 1988;24:81-101.
20. Verhoeff AP, van Reenen-Hoekstra ES, Samson RA, et al. Fungal propagules in house dust. I. Comparison of analytic methods and their value as estimators of potential exposure. Allergy 1994;49:533-9.
21. Chew G, Douwes J, Doekes G, et al. Fungal extracellular polysaccharides, β(1 → 3)-glucans, and culturable fungi in repeated sampling of house dust. Indoor Air 2001;11:171-8.
22. Heederik D, Attfield M. Characterization of dust exposure for the study of chronic occupational lung disease: a comparison of different exposure assessment strategies. Am J Epidemiol 2000;151:982-90.
23. Heederik D, Douwes J, Thorne PS. Biological agents - evaluation. In: Perkins JL, ed. Modern industrial hygiene. Vol 2. Biological aspects. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, 2003:293-327.
24. Dales RE, Miller D, McMullen E. Indoor air quality and health: validity and determinants of reported home dampness and moulds. Int J Epidemiol 1997:26:120-5.
25. Verhoeff AP, van Strien RT, van Wijnen JH, et al. Damp housing and childhood respiratory symptoms: the role of sensitization to dust mites and molds. Am J Epidemiol 1995:141:103-10.
26. Miller JD, Young JC. The use of ergosterol to measure exposure to fungal propagules in indoor air. Am Ind Hyg Assoc J 1997;58:39-43.
27. Pasanen A-L, Yli-Pietilä K, Pasanen P, et al. Ergosterol content in various fungal species and biocontaminated building materials. Appl Environ Microbiol 1999;65:138-42.
28. Douwes J, van der Sluis B, Doekes G, et al. Fungal extracellular polysaccharides in house dust as a marker for exposure to fungi: relations with culturable fungi, reported home dampness and respiratory symptoms. J Allergy Clin Immunol 1999;103:494-500.
29. Douwes J, Doekes G, Montijn R, et al. Measurement of β(1 → 3)-glucans in the occupational and home environment with an inhibition enzyme immunoassay. Appl Environ Microbiol 1996;62:3176-82.
30. Aketagawa J, Tanaka S, Tamura H, et al. Activation of limulus coagulation factor G by several (1 → 3)-β-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J Biochem 1993;113: 683-6.
31. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000;55:501-4.
32. Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002;325:411-14.
33. Halonen M, Stern DA, Wright AL, et al. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997;155:1356-61.
34. Rylander R. Indoor air-related effects and airborne (1 → 3)-β-D-glucan. Environ Health Perspect 1999;107(suppl 3):501-3.
35. Douwes J, Zuidhof A, Doekes G, et al. (1 → 3)-β-D-Glucan and endotoxin in house dust and peak flow variability in children. Am J Respir Crit Care Med 2000;162:1348-54.
36. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious diseases perspective. Clin Microbiol Rev 2003;16:144-72.
37. Korpi A, Kasanen JP, Kosma AY. Sensory irritating potency of some microbial volatile organic compounds (MVOCs) and a mixture of five MVOCs. Arch Environ Health 1999;54:347-52.
38. Holt PG, Sly PD, Björkstén B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 1997;8:53-8.
39. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354:12-15.
40. Matricardi PM, Rosmini F, Ferrigno L, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997;314:999-1003.
41. Shaheen SO, Aaby P, Hall AJ, et al. Cell mediated immunity after measles in Guinea-Bissau: historical cohort study. BMJ 1996;313:969-74.
42. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.
43. Aaby P, Shaheen SO, Heyes CB, et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000;30:644-50.
44. Gereda JE, Leung DY, Thatayatikom A, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000;355:1680-3.
45. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-77.
46. Douwes J, Pearce N, Heederik D. Does bacterial endotoxin prevent asthma? Thorax 2002;57:86-90.